Physical Pharmaceutics II Hub
BP402T Preformulation Studies (Complete Notes)
By Arvind Sharma, B.Pharm, M.Pharm, Assistant Professor, MUIT
PHARMACEUTICS: PREFORMULATION MASTERCLASS
PREFORMULATION: FOUNDATIONAL CONCEPTS
Learning Objectives
- Understand the initiation phase of preformulation studies.
- Categorize the primary areas of preformulation analysis.
- Recognize key parameters within bulk, solubility, and stability characterization.
Preformulation commences when a newly synthesized drug shows sufficient pharmacologic promise in animal models, initiating a detailed investigation into its physical and chemical properties crucial for formulation development.
I. BULK CHARACTERIZATION
| Key Parameter | Description / Significance |
|---|---|
Crystallinity and Polymorphism | Understanding crystal forms and their impact on solubility, stability, and bioavailability. |
Hygroscopicity | Assessing moisture absorption characteristics and its effect on physical stability. |
Fine Particle Characterization | Analyzing particle size, shape, and surface area, critical for dissolution and flow. |
Bulk Density | Measuring the mass per unit volume of a powder, influencing flow and compaction. |
Powder Flow Properties | Evaluating the ability of powder to flow, essential for manufacturing processes like tablet compression and capsule filling. |
II. SOLUBILITY ANALYSIS
| Key Parameter | Description / Significance |
|---|---|
Ionisation Constant – pKa pH | Determining the extent of ionization at various pH levels, critical for absorption and solubility. |
Solubility Profile | Mapping drug solubility across a range of pH values and solvent systems. |
Common Ion Effect – Ksp | Investigating how the presence of common ions affects intrinsic solubility. |
Thermal Effects | Studying the influence of temperature on solubility and potential for degradation. |
Solubilization | Methods to enhance drug solubility, such as micellar solubilization or complexation. |
Partition Coefficient | Assessing the lipophilicity/hydrophilicity balance, crucial for membrane permeability. |
Dissolution | Measuring the rate at which a solid drug dissolves in a solvent, a key determinant of bioavailability. |
III. STABILITY ANALYSIS
| Stability Aspect | Description / Key Considerations |
|---|---|
Stability in Toxicology Formulations | Ensuring drug integrity during animal toxicity studies. |
Solution Stability
| Assessing chemical and physical stability when the drug is dissolved. |
Solid State Stability | Evaluating the drug's stability in its solid form, considering factors like light, temperature, and humidity. |
Bulk Stability
| Overall stability of the drug substance in its bulk form prior to formulation. |
CRYSTALLINITY AND POLYMORPHISM DEEP DIVE
Crystallinity
- Outer appearance (External structure) – This refers to the macroscopic morphology, known as the “Habit.”
- Inner appearance (Internal structure) – This refers to the atomic or molecular arrangement within the solid, defining the “Crystal.”
Polymorphism
The state of a substance existing in more than one distinct crystalline form is called Polymorphism.
Classification of Polymorphs
| Polymorph Type | Characteristics | Reversibility | Example |
|---|---|---|---|
| Enantiotropic | One polymorph can be reversibly changed into another by varying temperature or pressure. | Reversible | Sulphur |
| Monotropic | One polymorphic form is unstable at all temperatures and pressures; transformation is irreversible. | Irreversible | Glyceryl stearates |
Transition Temperature & Van't Hoff Plots
- The temperature at which two polymorphs have identical free energies (i.e., same solubility and vapour pressure) is defined as the transition temperature.
- Transition temperature is typically obtained by extrapolation of Van’t Hoff plots.
Van’t Hoff plot is a graphical representation of Log Molar Solubility vs. Temperature, used to determine thermodynamic parameters.
- Bridging solvent – A solvent that facilitates the conversion of one polymorph to another.
MICROSCOPY IN PREFORMULATION
| Property | Description | Refractive Indices |
|---|---|---|
| Isotropic | Exhibits a single refractive index. | One |
| Anisotropic | Exhibits more than one refractive index. | More than one |
Sub-classification of Anisotropic Materials:
| Type | Number of Refractive Indices |
|---|---|
| Uniaxial | Two refractive indices |
| Biaxial | Three refractive indices |
MOISTURE CONTENT ANALYSIS
| Method | Principle / Application |
|---|---|
| TGA (Thermogravimetric Analysis) | Measures mass change as a function of temperature, ideal for quantifying moisture loss. |
| Karl Fischer Titration | Specific method for water content determination using a volumetric or coulometric titration. |
| Gas Chromatography | Separates and quantifies volatile components, including water, in a sample. |
| Gravimetry | Measures mass change upon drying to determine moisture content. |
FINE PARTICLE CHARACTERIZATION
1. Particle Size Determination Methods:
| Method | Principle / Device Type |
|---|---|
| Coulter counter | Electrical sensing zone method (stream counting device). |
| HIAC | Light obscuration method (stream counting device). |
| Optical Microscopy | Direct visualization and measurement of particles. |
2. Surface Area Determination:
| Method | Key Parameters / Notes |
|---|---|
| Brunauer-Emmett-Teller (BET) Adsorption |
|
| Gas Adsorption | No. of moles = Weight in gram / Molecular Weight. |
Note: Effective Surface Area exposed to dissolution media is critical for bioavailability.
3. Particle Morphology Characterization:
| Method | Key Aspect |
|---|---|
| Scanning Electron Microscope (SEM) | Provides high-resolution images of particle surface topography. |
| Gold coating | Applied to samples for SEM to make the surface superconductive, preventing charge buildup. |
SOLUBILITY & pKa DETERMINATIONS
Solubility (mg/ml) Analytical Methods:
| Method | Principle / Application |
|---|---|
| UV (Ultraviolet Spectroscopy) | Measures absorption of UV light by the drug. |
| HPLC (High-Performance Liquid Chromatography) | Separates and quantifies the dissolved drug. |
| GC (Gas Chromatography) | For volatile or derivatizable drugs. |
| Fluorimetry | Measures fluorescence intensity, highly sensitive for fluorescent drugs. |
pKa Determinations
The Henderson-Hasselbach equation provides an estimate of the ionized and un-ionized drug concentration at a particular pH, crucial for predicting absorption and distribution.
Henderson-Hasselbach Equations:
| Compound Type | Equation |
|---|---|
| Acidic Compounds | pH = pKa + log [ionized drug] / [unionized drug] |
| Basic Compounds | pH = pKa + log [unionized drug] / [ionized drug] |
pKa Determination Methods:
| Method | Principle |
|---|---|
| Spectral shift in UV | Monitoring changes in UV absorption spectra with pH. |
| Potentiometry | Measuring pH changes during titration with acid or base. |
PARTITION COEFFICIENT (Ko/w)
Ko/w = Co / Cw, where Co is the concentration of drug in the organic phase (e.g., octanol) and Cw is the concentration in the aqueous phase.
Key takeaway: Higher the partition coefficient, greater is the lipophilicity of the drug, which influences membrane permeability.
DISSOLUTION PRINCIPLES
Dissolution is typically expressed in units of mg/min, representing the mass of drug dissolved per unit time.
Modified Noyes-Whitney Equation:
dc / dt = DA / hV (Cs – C)
Where:
| Symbol | Description |
|---|---|
| D | The diffusion coefficient of the drug in the dissolution medium. |
| h | The thickness of the diffusion layer surrounding the solid particle. |
| A | The surface area of the dissolving solid drug. |
| V | The volume of the dissolution media. |
| Cs | The concentration of a saturated solution of the solute in the dissolution medium. |
| C | The concentration of drug in solution at time, t. |
- Intrinsic Dissolution Rate (IDR): A fundamental dissolution parameter, expressed in units of mg cm-2 min-1.
- The ionic strength of isotonic 0.9% w/w NaCl is approximately 0.15.
SURFACE DISCOLORATION STUDY (MOTTLING)
| Method | Application |
|---|---|
| Tristimulus reflectance spectroscopy | Measures color changes based on L*a*b* color space. |
| Diffuse reflectance spectroscopy | Analyzes light reflected from surfaces to characterize discoloration. |
| Microreflectance photometry | Localized measurement of reflectance for small surface areas. |
Key Method: The Stability Indicating Assay Method of choice is often HPLC due to its specificity and sensitivity for detecting drug degradation products.
SOLUBILITY CLASSIFICATION (USP/BP)
| Solubility Term | Parts of Solvent to Dissolve 1 Part of Solute |
|---|---|
| Very soluble | Less than 1 |
| Freely soluble | 1-10 |
| Soluble | 10-30 |
| Sparingly soluble | 30-100 |
| Slightly soluble | 100-1000 |
| Very slightly soluble | 1000-10,000 |
| Practically insoluble | More than 10,000 |
GLASS TRANSITION TEMPERATURE (Tg)
Glass Transition Temperature (Tg) is the temperature at which a material transitions from a rigid, glassy state to a more flexible, rubbery state, specifically observed during the amorphous phase of a substance.
BIOPHARMACEUTICAL CLASSIFICATION SYSTEM (BCS)
| BCS Class | Solubility | Permeability | Implication |
|---|---|---|---|
| I | High | High | Well absorbed, dissolution is not rate-limiting. |
| II | Low | High | Dissolution is often the rate-limiting step for absorption. |
| III | High | Low | Permeability is the rate-limiting step for absorption. |
| IV | Low | Low | Poorly absorbed, significant challenges for oral delivery. |
Clinical Relevance: The BCS framework guides drug development by predicting the in vivo absorption of orally administered drugs based on solubility and permeability, impacting formulation strategies and regulatory waivers.
COMPRESSIBILITY AND FLOWABILITY OF PHARMACEUTICAL EXCIPIENTS
| % Compressibility (Carr's Index) | Flowability Rating |
|---|---|
| 5-15 | Excellent |
| 12-16 | Good |
| 18-21 | Fair-passable |
| 23-35 | Poor |
| 33-38 | Very poor |
| < 40 | Very, very poor |
CRYSTAL PURITY & ANALYTICAL METHODS FOR SOLID FORMS
Methods for Assessing Crystal Purity and Solid Form:
| Method | Primary Application |
|---|---|
| DSC (Differential Scanning Calorimetry) | Evaluates thermal transitions (melting, glass transition), useful for Drug-Excipient compatibility studies. |
| XRD (X-ray Diffraction) | Characterizes crystal structure and identifies polymorphic forms, essential for Study of polymorphism. |
X-ray Diffraction (XRD) – Bragg's Law
nλ = 2d sin θ
Where:
| Symbol | Description |
|---|---|
| n | An integer representing the order of diffraction. |
| λ | The wavelength of the incident X-ray beam. |
| d | The interplanar distance between crystal lattice planes. |
| θ | The angle of diffraction (Bragg angle). |
XRD Peak Interpretation:
- Sharp peak: Indicates a highly Crystalline material.
- No peak (or broad halo): Characteristic of an Amorphous material.
Additional Analytical Methods for Characterization of Solid Forms:
| Method | Application |
|---|---|
| Hot Stage Microscopy | Direct visual observation of thermal events (e.g., melting point, phase transitions) under a microscope. |
| Differential Scanning Calorimetry (DSC) | Measures heat flow associated with thermal transitions as a function of temperature or time. |
SOLVENT POWER INDEX
| Solvent | Relative Solvent Power |
|---|---|
| Glycerol | 0.5 |
| Propylene glycol | 1 |
| Ethanol | 2 |
| DMF / DMA | 4 |
Note: This relative scale provides a general indication; actual solvent power can vary depending on the solute and specific conditions.
KEY PHARMACEUTICAL EQUATIONS AND THEIR APPLICATIONS
| Equation | Primary Determination / Application |
|---|---|
| Noyes-Whitney | Dissolution rate of solid drugs. |
| BET (Brunauer-Emmett-Teller) | Surface area of powders. |
| Stokes' Law | Sedimentation rate of particles in a fluid. |
| Higuchi Equation | Release of drug from granular matrix systems. |
| Henderson-Hasselbach | Relationship between pH, pKa, and ionized/unionized drug fractions. |
| Young's Equation | Characterizes properties of surfactant interaction with solid surfaces (contact angle). |
| Arrhenius Equation | Predicts stability of drug / product at Room Temperature (R.T.) from accelerated temperature data. |
Exam Pearl: Understanding the fundamental application of these equations is crucial for problem-solving and conceptual understanding in pharmaceutics.
PCI Verified Active 8 min read